FDA Guidance Raises Prospect Of More INDs For Supplement Research
This article was originally published in The Tan Sheet
Executive Summary
An FDA draft guidance that seeks to clarify when an investigational new drug application should be filed may add logistical knots to the process of studying foods and dietary ingredients, stakeholders say.